越南人对认知衰老计划 (VIP) 的见解:目标,研究设计和队列描述
Oanh L Meyer1, Sarah Tomaszewski Farias1, Rachel A Whitmer1
1School of Medicine University of California, Davis Sacramento California USA.
Alzheimer's & dementia (New York, N. Y.)
|July 23, 2024
概括
越南人对认知衰老的洞察力计划 (VIP) 研究了早期生活中的逆境和战争创伤如何影响老年越南裔美国人的认知健康. 这项研究旨在减少研究不足的人群中痴呆症差异.
科学领域:
- 老年学是一门学科.
- 神经科学是一个神经科学.
- 公共卫生 公共卫生
背景情况:
- 亚裔美国人,特别是越南裔美国人的认知衰老和痴呆症研究有限.
- 越南裔美国人是美国第四大亚裔子群体.
研究的目的:
- 调查早期生活逆境,与战争有关的创伤和老年越南裔美国人的认知健康之间的联系.
- 检查认知功能,包括全球认知,执行功能,语义记忆和情节记忆.
- 确定导致认知能力下降的心理社会和心血管风险因素.
主要方法:
- 越南洞察认知衰老计划 (VIP) 是一个基于社区的纵向研究.
- 基线数据来自北加利福尼亚州的548名越南裔美国人 (平均年龄73岁).
- 综合的神经心理测试,功能,创伤暴露和风险因素评估.
主要成果:
- 在2022年1月至2023年11月期间完成的基线评估.
- 在研究地点之间观察到教育,收入和英语水平的显著差异.
- 大多数参与者报告说,他们会说一些或没有英语.
结论:
- 这项研究提供了一个独特的机会,以了解不充分参与的人群中痴呆症差异.
- 未来的分析将探讨认知,轻度认知障碍和痴呆症患病率,控制位点差异.
- 这些发现可以为干预提供信息,并减少不同群体中阿尔茨海默病和相关痴呆症 (ADRD) 的负担.
相关概念视频
Cognitive Development During Adulthood
76
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
76
Longitudinal Research
11.9K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
11.9K
Alzheimer's Disease: Overview
456
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
456
Aging
41
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
41
Cognitivism
1.4K
Cognitive psychology emerged as a significant field in the mid-20th century. It focused on understanding humans' internal mental processes. This approach emphasizes how people perceive, remember, think, and solve problems—elements critical to human cognition.
Previously dominated by behaviorism, which prioritized observable behaviors and largely ignored mental processes, psychology transformed in the 1950s. Cognitive psychologists argue that understanding how we think and process...
Previously dominated by behaviorism, which prioritized observable behaviors and largely ignored mental processes, psychology transformed in the 1950s. Cognitive psychologists argue that understanding how we think and process...
1.4K
Alzheimer's Disease: Treatment
172
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
172


